trending Market Intelligence /marketintelligence/en/news-insights/trending/HgsPiJSVoQwco0Kd95ZB-Q2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Vaxart to raise $3M in common stock offering


Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection


Banking Essentials Newsletter - February Edition


Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Vaxart to raise $3M in common stock offering

Vaxart Inc. is offering 1.2 million common shares priced at $2.50 apiece in a registered direct offering.

The transaction, which is being participated by certain institutional investors, is expected to generate $3 million in gross proceeds.

The closing of the offering will occur March 20.

H.C. Wainwright & Co. is acting as exclusive placement agent for the offering.

South San Francisco, Calif.-based Vaxart is focused on developing oral vaccines using its proprietary oral vaccine platform.